Latest Insider Transactions at Ardelyx, Inc. (ARDX)
This section provides a real-time view of insider transactions for Ardelyx, Inc. (ARDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARDELYX, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARDELYX, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 20
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
1,489
-0.37%
|
$0
$0.67 P/Share
|
May 20
2022
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,425
-1.02%
|
$0
$0.67 P/Share
|
May 20
2022
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,528
-0.45%
|
$0
$0.67 P/Share
|
May 20
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
524
-0.49%
|
$0
$0.67 P/Share
|
May 20
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,489
-0.43%
|
$0
$0.67 P/Share
|
Feb 22
2022
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,400
-1.01%
|
$0
$0.67 P/Share
|
Feb 22
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
601
-0.57%
|
$0
$0.67 P/Share
|
Feb 22
2022
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,752
-0.5%
|
$0
$0.67 P/Share
|
Feb 22
2022
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
1,528
-0.48%
|
$0
$0.67 P/Share
|
Feb 22
2022
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
6,229
-0.8%
|
$0
$0.67 P/Share
|
Feb 22
2022
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
1,752
-0.44%
|
$0
$0.67 P/Share
|
Feb 22
2022
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,800
-0.54%
|
$0
$0.67 P/Share
|
Jan 06
2022
|
Michael Raab President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+16.1%
|
-
|
Jan 06
2022
|
Elizabeth A Grammer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+11.67%
|
-
|
Jan 06
2022
|
Robert Blanks Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+9.07%
|
-
|
Jan 06
2022
|
Susan Rodriguez Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,000
+29.43%
|
-
|
Jan 06
2022
|
Justin A Renz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+11.12%
|
-
|
Jan 06
2022
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
15,000
+12.44%
|
-
|
Jan 06
2022
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+10.23%
|
-
|
Dec 15
2021
|
Forest Baskett > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,211,352
-12.52%
|
$1,211,352
$1.14 P/Share
|
Dec 15
2021
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,211,352
-12.52%
|
$1,211,352
$1.14 P/Share
|
Dec 14
2021
|
Forest Baskett > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,735
-7.72%
|
$1,000,735
$1.24 P/Share
|
Dec 14
2021
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,735
-7.72%
|
$1,000,735
$1.24 P/Share
|
Dec 09
2021
|
Forest Baskett > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
669,483
-4.91%
|
$669,483
$1.51 P/Share
|
Dec 09
2021
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
669,483
-4.91%
|
$669,483
$1.51 P/Share
|
Nov 22
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
537
-0.19%
|
$0
$0.99 P/Share
|
Nov 22
2021
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
643
-0.18%
|
$0
$0.99 P/Share
|
Nov 22
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,754
-2.31%
|
$0
$0.99 P/Share
|
Nov 22
2021
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
2,607
-0.41%
|
$0
$0.99 P/Share
|
Nov 22
2021
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
643
-0.22%
|
$0
$0.99 P/Share
|
Nov 22
2021
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
643
-0.33%
|
$0
$0.99 P/Share
|
Nov 22
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
184
-0.2%
|
$0
$0.99 P/Share
|
Nov 22
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
643
-0.21%
|
$0
$0.99 P/Share
|
Nov 15
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.84%
|
$5,000
$1.13 P/Share
|
Nov 12
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
77,432
-21.88%
|
$77,432
$1.12 P/Share
|
Nov 08
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,166
-1.64%
|
$2,166
$1.18 P/Share
|
Oct 08
2021
|
Elizabeth A Grammer Officer |
SELL
Grant, award, or other acquisition
|
Direct |
250,000
-41.4%
|
-
|
Oct 08
2021
|
Justin A Renz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+45.93%
|
-
|
Oct 08
2021
|
Robert Blanks Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+40.88%
|
-
|
Oct 08
2021
|
Susan Rodriguez Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+43.14%
|
-
|
Oct 08
2021
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
60,000
+39.78%
|
-
|
Oct 08
2021
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+32.48%
|
-
|
Oct 08
2021
|
Michael Raab President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+32.11%
|
-
|
Aug 20
2021
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
631
-0.59%
|
$631
$1.32 P/Share
|
Aug 20
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
526
-0.51%
|
$526
$1.32 P/Share
|
Aug 20
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
741
-0.58%
|
$741
$1.32 P/Share
|
Aug 20
2021
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
2,573
-0.77%
|
$2,573
$1.32 P/Share
|
Aug 20
2021
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
631
-1.55%
|
$631
$1.32 P/Share
|
Aug 20
2021
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
630
-1.39%
|
$630
$1.32 P/Share
|
Aug 20
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
176
-0.66%
|
$176
$1.32 P/Share
|